Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 10-16 , 30 March 2010

Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress

  • Jason R. Lees

      Affiliations

    • Department of Surgery, 400 MSTF, 10 S. Pine St, University of Maryland School of Medicine, Baltimore, 21201-1509, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Julia Sim

      Affiliations

    • Department of Developmental Biology, Campus Box 8103, 660 South Euclid, Washington University, St. Louis, 63110, USA
    • ,
  • John H. Russell

      Affiliations

    • Department of Developmental Biology, Campus Box 8103, 660 South Euclid, Washington University, St. Louis, 63110, USA

Received 26 August 2009 ,Revised 17 November 2009 ,Accepted 24 November 2009.

References 

  1. Abrams SI, Wang R, Munger WE, Russell JH. Detachment and lysis of adherent target cells by CD4+ T cell clones involve multiple effector mechanisms. Cell. Immunol. 1993;147:188–202
  2. Archambault AS, Sim J, Gimenez MA, Russell JH. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur. J. Immunol. 2005;35:1076–1085
  3. Archelos JJ, Jung S, Maurer M, Schmied M, Lassmann H, Tamatani T, et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 1993;34:145–154
  4. Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009;462:94–98
  5. Bauer J, Bradl M, Hickley WF, Forss-Petter S, Breitschopf H, Linington C, et al. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 1998;153:715–724
  6. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. U. S. A. 1999;96:6896–6901
  7. Cohen JA, Essayan DM, Zweiman B, Lisak RP. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 1987;108:203–213
  8. Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity. 2001;14:547–560
  9. Flugel A, Odoardi F, Nosov M, Kawakami N. Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J. Neuroimmunol. 2007;191:86–97
  10. Gimenez MA, Sim JE, Russell JH. TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J Neuroimmunol. 2004;151:116–125
  11. Gleeson PA, Toh BH, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 1996;149:97–125
  12. Gold R, Hartung HP, Lassmann H. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends. Neurosci. 1997;20:399–404
  13. Goodin DS, Cohen BA, O'Connor P, Kappos L, Stevens JC. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;71:766–773
  14. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991;28:254–260
  15. Irani DN, Griffin DE. Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J. Immunol. Methods. 1991;139:223–231
  16. Jones RE, Mass M, Bourdette DN. Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice. J. Neuroimmunol. 1999;93:92–101
  17. Jones RE, Kay T, Keller T, Bourdette D. Nonmyelin-specific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis. J Immunol. 2003;170:831–837
  18. Kawai K, Ito K, Imamura K, Hickey WF, Zweiman B, Takahashi A. Enhancing effects of irrelevant lymphocytes on adoptive transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 1993;42:39–45
  19. Kawakami N, Nagerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flugel A. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 2005;201:1805–1814
  20. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004;117:265–277
  21. Krakowski ML, Owens T. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur. J. Immunol. 2000;30:1002–1009
  22. Lees JR, Archambault AS, Russell JH. T-cell trafficking competence is required for CNS invasion. J. Neuroimmunol. 2006;177:1–10
  23. Lees JR, Iwakura Y, Russell JH. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J. Immunol. 2008;180:8066–8072
  24. Ludowyk PA, Willenborg DO, Parish CR. Selective localisation of neuro-specific T lymphocytes in the central nervous system. J. Neuroimmunol. 1992;37:237–250
  25. Pender MP. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol. Cell. Biol. 1999;77:216–223
  26. Pender MP, Nguyen KB, McCombe PA, Kerr JF. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 1991;104:81–87
  27. Pender MP, McCombe PA, Yoong G, Nguyen KB. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmun. 1992;5:401–410
  28. Sakai K, Namikawa T, Kunishita T, Yamanouchi K, Tabira T. Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice. J. Immunol. 1986;137:1527–1531
  29. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 1993;143:446–452
  30. Vandenbark AA, Vainiene M, Celnik B, Hashim G, Offner H. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system. J. Neuroimmunol. 1992;39:251–260
  31. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992;356:63–66

PII: S0165-5728(09)00481-0

doi: 10.1016/j.jneuroim.2009.11.017

Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 10-16 , 30 March 2010

Article Tools

* Image Usage & Resolution